Albert Agro

Albert Agro was the founder of GRI Bio Operations, Inc., founded in 2009, where the title held was Chief Medical Officer & Director from 2017 to 2023.
Dr. Agro is currently Chief Executive Officer & Director at Jocasta Neuroscience, Inc. since 2024, Director at Saint Elizabeth Health Care, and Chief Medical Officer at GRI Bio, Inc. since 2023.
Former positions include President, Chief Executive Officer & Director at Sublimity Therapeutics Ltd. from 2018 to 2021; Chief Executive Officer at HNZ Strategic Holdings, Inc.; Director-Cardiopulmonary Research Division at Bayer, Inc. from 1998 to 2000; Senior Vice President-Clinical Development at VTVX Holdings I LLC from 2007 to 2009; Chief Medical Officer at Trillium Therapeutics, Inc.; Chief Medical Officer at Cynapsus Therapeutics, Inc. from 2010 to 2016; Assistant Professor at McMaster University; Principal at Boehringer Ingelheim Pharmaceuticals, Inc.; and Chief Medical Officer at Vallon Pharmaceuticals, Inc. Education includes a doctorate from McMaster University conferred in 1995.